Abortion pills at SCOTUS: The Louisiana mifepristone case, explained
Abortion pills have been on a bit of a journey in the United States over the past few weeks.It starts...
SCOTUS
Liquidia: Attractive Entry Point After Undeserved SCOTUS Appeal Reaction (NASDAQ:LQDA)
Chris Ryan In our previous article on Liquidia, we discussed the rich catalyst path for value unlocking, we cited significant...
‘Stop pretending’: Conservative activist wants Dems behind SCOTUS ethics rules to take their own medicine
A prominent conservative activist and philanthropist is pushing back against President Biden's newly unveiled plan to make drastic changes to...
